Skip to content

Peter MD review

By Marcus HaleLongevity Research Editor
Updated

Package price for an 8-10 week supply, not a flat monthly rate

$369 buys two 200mg/ml vials sized to last 8-10 weeks; the $147-184/month figure is our own division of that price, not a rate Peter MD advertises as monthly.

$369 / 8-10 wks

We may earn a commission if you sign up through our links, at no cost to you. How we make money.

Key details

Advertised price
"$369" for 2 vials (200mg/ml), stated as an 8-10 week supply, printed on the NAD+ product page.
Billing details
Roughly $147-184/month depending on how the 8-10 week supply is used — our own division of $369 by the stated supply window, not a figure Peter MD publishes as a monthly rate.
Pharmacy
Named in the Terms, not on the product page. Section 23 of Peter MD's terms and conditions page is headed "Pharmacy Disclosure" and lists Absolute Pharmacy (16011 N Nebraska Ave #103, Lutz, FL 33549 — (813) 999-2700) and Partell Pharmacy (5835 S. East Ave, Las Vegas, NV — (702) 791-3800), repeated on the delivery-policy page. Neither is classified: no 503A or 503B designation appears on the NAD+ product page or anywhere else, and Peter MD publishes no NPI.
Availability
Not published as a list on the NAD+ product page; like most compounded telehealth, Peter MD is not available in every state and coverage should be confirmed at intake.
Comparison
Listed on our NAD+ provider index.

Our verdict

Peter MD sells a physician-prescribed injectable NAD+ protocol — two 200mg/ml vials for $369, sized to last 8-10 weeks — alongside a broader menu of tirzepatide, semaglutide, sermorelin and TRT for patients who want more than NAD+ from one provider. The $369 figure is printed on the product page itself, which puts it ahead of sellers who gate every number behind an intake, but it is a package price rather than a monthly one: the $147-184/month range here is arithmetic we did dividing $369 by the supply window, not a number Peter MD states as a monthly rate. The company also markets its protocol as "backed by 100+ clinical studies," a claim we treat as the company's own promotional language rather than a citation we could verify.

NAD+ evidence

Compounded NAD+ is not an FDA-approved product, and the route sold here has no randomized human trial behind it: there is no published study showing that subcutaneous or intranasal NAD+ raises blood NAD+ in people, let alone that it improves energy, focus or any aging endpoint. What the clinical literature actually supports is the oral precursor NR, which does raise blood NAD+ in controlled trials — a different molecule by a different route. Peter MD markets its protocol as "backed by 100+ clinical studies," but that is the company's own promotional language rather than a citation we could verify — the same evidence gap applies here as to every other injectable or intranasal NAD+ seller here.

Pricing and fees

Advertised price
"$369" for 2 vials (200mg/ml), stated as an 8-10 week supply, printed on the NAD+ product page.
Payment terms
Roughly $147-184/month depending on how the 8-10 week supply is used — our own division of $369 by the stated supply window, not a figure Peter MD publishes as a monthly rate.
Pricing details
A package price for a multi-week supply rather than a subscription rate. Nothing on the product page converts $369 into a monthly figure or states how the injection frequency is meant to work across the 8-10 week window, so a reader has to do that math themselves rather than compare it directly against providers who publish a flat monthly number.

Additional fees

  • Also sells tirzepatide, semaglutide, sermorelin and TRT — priced and billed separately from the NAD+ line
  • No membership fee, lab fee or shipping cost is stated on the NAD+ product page we reviewed

Prices are from Peter MD's own website and can change without notice.

Who it may suit

May suit you if

  • You specifically want injectable NAD+ from a physician-prescribed telehealth provider
  • You would rather pay once for a multi-week supply than commit to an ongoing monthly subscription
  • You might also want tirzepatide, semaglutide, sermorelin or TRT from the same provider later

Consider another option if

  • You want a single clean monthly price you can budget against without doing the math yourself
  • You want a route other than injection — Peter MD's NAD+ line here is injectable, not nasal, oral or troche
  • You want the compounding pharmacy named on the product page, or any 503A/503B designation at all
  • You live in a state Peter MD does not serve

What’s included

Consultation
Yes — Peter MD is physician-prescribed telehealth; a clinician review precedes the NAD+ prescription.
Lab testing
Not stated on the product page we reviewed.
Follow-up care
Not detailed on the product page we reviewed.
Clinical support
Not detailed on the product page we reviewed.
Supplies
Two 200mg/ml NAD+ vials per $369 order; whether needles/syringes are included is not stated on the page we reviewed.
Shipping
Not detailed on the product page we reviewed.

Limitations and policy details

Peter MD's most visible marketing claim — that its NAD+ protocol is "backed by 100+ clinical studies" — is the company's own promotional language, not a citation to a specific study we could check. Injected NAD+ has no rigorous human trial evidence behind it, however many studies a seller says exist. The price has a similar shape: $369 for two vials is a package figure for an 8-10 week supply, not a monthly rate, so the $147-184/month range depends entirely on how quickly you work through the vials — something Peter MD's own product page never spells out. Customer reviews of Peter MD are mixed, and the NAD+ product page names no compounding pharmacy and no 503A/503B designation.

Other considerations

  • Priced as an 8-10 week package ($369 for 2 vials) rather than a clean monthly figure — the $147-184/month range is our own math, not a number Peter MD states as a monthly rate
  • The "backed by 100+ clinical studies" claim is Peter MD's own marketing language; we did not verify it, and injectable NAD+ still has no published human trial showing it raises blood NAD+ or improves any measurable outcome
  • Not available in every state — coverage should be confirmed during intake, and this is not detailed on the pricing page itself
  • Customer reviews are mixed, and the NAD+ product page names no pharmacy and states no 503A/503B designation — the two it does name, Absolute and Partell, are in section 23 of the Terms

Cost calculators

How this site makes money

We may earn a commission when you buy a product or start care through our links, at no extra cost to you. Affiliate partners appear first in our provider comparison. Read the full disclosure.

View Peter MD

Every figure on this page comes from Peter MD’s own site, and prices change without notice. Compare it against the rest of the field on our NAD+ provider index, or read every provider review.

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.